R&D News | pharmaphorum

News

Cognition Therapeutics' chief executive Lisa Ricciardi

Cognition's SHINE data for Alzheimer's drug dulls prospects

Cognition Therapeutics has reported phase 2 data with its Alzheimer's disease candidate, claiming the results show proof-of-concept for the drug, although the study missed its main endpoint

News

Boehringer buys oncology player Nerio in $1.3bn deal

Boehringer Ingelheim has bought Nerio Therapeutics, saying that it is adding a programme that – while still in preclinical development – could be a "centrepiece" of its immuno-oncology pipe

News

GSK joins Flagship's flotilla of pharma partners

Flagship Pioneering has signed yet another strategic-level deal with a big pharma group, with GSK the latest to tap into its network of biotech companies in an alliance that could be worth

News

NewAmsterdam Pharma's chief executive Michael Davidson

NewAmsterdam obicetrapib data disappoints some investors

Shares in NewAmsterdam Pharma were sliding today after it reported a phase 3 trial of obicetrapib that met its primary objective but didn't meet the expectations of some analysts and invest

News

AMPLIFY results dial up Calquence's potential in CLL

AstraZeneca's Calquence has hit the mark in the phase 3 AMPLIFY trial in chronic lymphocytic leukaemia (CLL), a study that chief executive Pascal Soriot recently said could be a "blockbuste

News

Third Arc's $165m for T cell engagers, plus other bio rounds

This week's round-up of new financings in the biotech world is headed by a big round for Third Arc, a specialist in T-cell engager antibodies, with Autobahn, Brenig, Confo, and GRO Bio also

Cognition's SHINE data for Alzheimer's drug dulls prospects

Boehringer buys oncology player Nerio in $1.3bn deal

GSK joins Flagship's flotilla of pharma partners

NewAmsterdam obicetrapib data disappoints some investors

AMPLIFY results dial up Calquence's potential in CLL

Third Arc's $165m for T cell engagers, plus other bio rounds

Bankruptcy threat looms as Quince runs out of options

How to meet your physicians where they are online

News

Editor's Picks